Rock Springs Capital Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-125,000
Closed -$5.19M 127
2023
Q2
$5.19M Hold
125,000
0.12% 87
2023
Q1
$7.52M Hold
125,000
0.18% 81
2022
Q4
$9.17M Sell
125,000
-50,000
-29% -$3.76M 0.22% 77
2022
Q3
$13.3M Hold
175,000
0.34% 68
2022
Q2
$12.2M Hold
175,000
0.35% 69
2022
Q1
$14.5M Hold
175,000
0.37% 72
2021
Q4
$13.1M Hold
175,000
0.3% 81
2021
Q3
$20.3M Hold
175,000
0.43% 73
2021
Q2
$38.8M Hold
175,000
0.77% 47
2021
Q1
$23.1M Hold
175,000
0.5% 67
2020
Q4
$30.3M Hold
175,000
0.64% 52
2020
Q3
$19.5M Hold
175,000
0.49% 66
2020
Q2
$10.4M Hold
175,000
0.28% 102
2020
Q1
$11.8M Buy
175,000
+2,500
+1% +$198K 0.49% 68
2019
Q4
$14.5M Hold
172,500
0.46% 74
2019
Q3
$12.9M Sell
172,500
-22,500
-12% -$1.8M 0.51% 62
2019
Q2
$12.3M Hold
195,000
0.45% 75
2019
Q1
$9.39M Hold
195,000
0.36% 85
2018
Q4
$6.53M Buy
195,000
+170,000
+680% +$6.22M 0.31% 84
2018
Q3
$1.31M Buy
+25,000
New +$995K 0.05% 138
2017
Q2
Sell
-214,316
Closed -$1.74M 154
2017
Q1
$1.74M Hold
214,316
0.1% 125
2016
Q4
$1.68M Hold
214,316
0.11% 117
2016
Q3
$1.83M Hold
214,316
0.11% 121
2016
Q2
$2.5M Hold
214,316
0.19% 109
2016
Q1
$3.1M Hold
214,316
0.26% 100
2015
Q4
$4.79M Buy
+214,316
New +$5.12M 0.36% 89

Other funds holding NVCR

Rock Springs Capital Management's NVCR Position: Q3 2023 in Review

Rock Springs Capital Management sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 125,000 shares — an estimated $5.19M sold.

Rock Springs Capital Management first reported a position in NVCR in Q4 2015 and held it in 26 quarters. The position peaked at $38.8M in Q2 2021. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

  • Rock Springs Capital Management reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
  • Rock Springs Capital Management sold 125,000 NovoCure shares in Q3 2023, an estimated $5.19M.
  • Rock Springs Capital Management first reported a position in NovoCure in Q4 2015 and held it in 26 quarters.
  • Rock Springs Capital Management's NovoCure position peaked at $38.8M in Q2 2021.
  • 226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Rock Springs Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.